1. ScheuerP. Liver biopsy size matters in chronic hepatitis: bigger is better. Hepatology2003;38:1356. CrossRef

2. LeeS, KimDY. Non‐invasive diagnosis of hepatitis B virus‐related cirrhosis. World J Gastroenterol2014;20:445. CrossRef

3. BedossaP, DargèreD, ParadisV. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology2003;38:1449. CrossRef

4. LindorK, BruC, JorgensenRA, et al.The role of ultrasonography and automatic needle biopsy in outpatient percutaneous liver biopsy. Hepatology1996;23:1079. CrossRef

5. GrantA, NeubergerJ. Guidelines on the use of liver biopsy in clinical practice. Gut1999;45(Suppl 4):IV1. CrossRef

6. SmithTP, PressonT, HeneghanM, et al.Transjugular biopsy of the liver in pediatric and adult patients using an 18‐gauge automated core biopsy needle: a retrospective review of 410 consecutive procedures. Am J Roentgenol2003;180:167. CrossRef

7. McMahonC, PilkingtonR, SheaEO, et al.Liver biopsy in Irish hepatitis C infected patients with inherited bleeding disorders. Br J Haematol2000;109:354. CrossRef

8. AhmadA, HasanF, AbdeenS, et al.Transjugular liver biopsy in patients with end‐stage renal disease. J Vasc Interv Radiol2004;15:257. CrossRef

9. ProcopetB, BureauC, MétivierS, et al.Tolerance of liver biopsy in a tertiary care center: comparison of the percutaneous and the transvenous route in 143 prospectively followed patients. Eur J Gastroenterol Hepatol2012;24:1209. CrossRef

10. BanaresR, AlonsoS, CatalinaMV, et al.Randomized controlled trial of aspiration needle vs. automated biopsy device for transjugular liver biopsy. J Vasc Interv Radiol2001;12:583. CrossRef

11. FarrellRJ, SmiddyPF, PilkingtonRM, et al.Guided vs. blind liver biopsy for chronic hepatitis C: clinical benefits and costs. J Hepatol1999;30:580. CrossRef

12. SaadWE, RyanCK, DaviesMG, et al.Safety and efficacy of fluoroscopic versus ultrasound guidance for core liver biopsies in potential living related liver transplant donors: preliminary results. J Vasc Interv Radiol2006;17:1307. CrossRef

13. deManR, van BuurenH, HopeW. A randomized study on the efficacy and safety of an automated Tru‐Cut needle for percutaneous liver biopsy. Neth J Med2004;62:441.

14. DenzerU, Helmreich‐BeckerI, SchirmacherP, et al.Minilaparoscopy in the diagnosis of cirrhosis: superiority in patients with Child‐Pugh A and macronodular disease. J Clin Gastroenterol2007;41:103. CrossRef

15. RockeyDC, CaldwellSH, GoodmanZD, et al.Liver biopsy. Hepatology2009;49:1017. CrossRef

16. RileyTR. Predictors of pain medication use after percutaneous liver biopsy. Dig Dis Sci2002;47:2151. CrossRef

17. AlexanderJA, SmithBJ. Midazolam sedation for percutaneous liver biopsy. Dig Dis Sci1991;38:2209. CrossRef

18. PokornyC, WaterlandM. Short‐stay, out‐of‐hospital, radiologically guided liver biopsy. Med J Aust2002;176:67.

19. AhmedA, SamuelsSL, KeeffeEB, et al.Delayed fatal hemorrhage from pseudoaneurysm of the hepatic artery after percutaneous liver biopsy. Am J Gastroenterol2001;96:233. CrossRef

20. SeeffL, EversonT, MorganT, et al.Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT‐C Trial. Clin Gastroenterol Hepatol2010;8:877. CrossRef

21. PiccinioF, SagnelliE, PasqualeG, et al.Complications following percutaneous liver biopsy. A multi center retrospective study on 68 276 biopsies. J Hepatol1986;2:165. CrossRef

22. JanesCH, LindorKD. Outcome of patients hospitalized for complications after outpatient liver biopsy. Ann Intern Med1993;118:96. CrossRef

23. JonesOM, ReesM, JohnTG, et al.Biopsy of resectable colorectal liver metastases causes tumour dissemination and adversely affects survival after liver resection. Br J Surg2005;92:1165. CrossRef

24. ChauT, TongS, LiT, et al.Transjugular liver biopsy with an automated trucut‐type needle: comparative study with percutaneous liver biopsy. Eur J Gastroenterol Hepatol2002;14:19. CrossRef

25. TerjungB, LemnitzerI, DumoulinFL, et al.Bleeding complications after percutaneous liver biopsy. An analysis of risk factors. Digestion2003;67:138. CrossRef

26. van der PoortenD, KwokA, LamT, et al.Twenty‐year audit of percutaneous liver biopsy in a major Australian teaching hospital. Int Med J2006;36:692. CrossRef

27. HowlettDC, DrinkwaterKJ, LawrenceD, et al.Findings of the UK national audit evaluating image‐guided or image‐assisted liver biopsy. Part II. Minor and major complications and procedure‐related mortality. Radiology2013;266:226. CrossRef

28. WestheimBH, AagenæsI, ØstensenAB, et al.Effect of operator experience and frequency of procedure performance on complication rate after ultrasound‐guided percutaneous liver biopsies. J Pediatr Gastroenterol Nutr2013;57:638. CrossRef

29. SánchezCL, LenO, GavaldaJ, et al.Liver biopsy‐related infection in liver transplant recipients: a current matter of concern?Liver Transpl2014;20:552. CrossRef

30. ChevallierP, RuitortF, DenysA, et al.Influence of operator experience on performance of ultrasound‐guided percutaneous liver biopsy. Eur Radiol2004;14:2086. CrossRef

31. PinzaniM. Non‐invasive evaluation of hepatic fibrosis: don't count your chickens before they're hatched. Gut2006;55:310. CrossRef

32. YuI, DreizinD, TalalA, et al.Predictive value for low level hepatic fibrosis in chronic hepatitis C (CHC) patients: comparison of five non‐invasive indices [abstract]. J Hepatol2007;46:S214. CrossRef

33. Ganne‐CarriéN, ZiolM, de LedinghenV, et al.Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology2006;44:1511. CrossRef

34. MarcellinP, ZiolM, BedossaP, et al.Non‐invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int2009;29:242. CrossRef

35. LupsorMP, StefanescuH, FeierD, et al.Performance of unidimensional transient elastography in staging chronic hepatitis C. Results from a cohart of 1,202 biopsied patients from a single center. J Gastrointestin Liver Dis2013;22:157.

36. TapperEB, CasteraL, AfdahlNH. Fibroscan (vibration‐controlled transient elastography): where does it stand in the United States practice. Clin Gastroenterol Hepatol2015;13:27. CrossRef

37. LimB, LiewCT, CraigJR. Plastic embedded thin sections for light microscopy. Lab Med1981;12:145.

38. KerlinP, DavisGC, McGillDB, et al.Hepatic adenomas and focal nodular hyperplasia: clinical, pathologic and radiologic features. Gastroenterology1983;84:994.

39. GoodmanZD. Benign tumors of the liver. In: OkudaK, IshakKG(eds). Neoplasms of the Liver. Tokyo: Springer‐Verlag; 1987: 105. CrossRef

40. CraigJR, PetersRL, EdmondsonHA(eds). Tumors of the liver and intrahepatic bile ducts. In: Atlas of Tumor Pathology, 2nd Series, Fascicle 26. Washington, DC: Armed Forces Institute of Pathology; 1989: 123.

41. CraigJR, PetersRL, EdmondsonHA, et al.Fibrolamellar carcinoma of the liver. Cancer1980;46:372. CrossRef

42. KakarS, GownAM, GoodmanZD, et al.Best practices in diagnostic immunohistochemistry: Hepatocellular carcinoma versus metastatic neoplasms. Arch Pathol Lab Med2007;131:1648.

43. StromeyerFW, IshakKG. Nodular transformation (nodular regenerative hyperplasia) of the liver: a clinicopathologic study of 30 cases. Hum Pathol1981;12:60. CrossRef

44. LefkowitchJH. Hepatic granulomas. J Hepatol1999;30:40.

45. PetersRL. Viral hepatitis: a pathologic spectrum. Am J Med Sci1975;270:17. CrossRef

46. OkunoT, SaroA, DeguchiT, et al.Pathology of acute hepatitis A in humans: a comparison with acute hepatitis B. Am J Clin Pathol1984;81:162.

47. DeKockKM, BradleyDW, SanfordNL, et al.Epidemic non‐A, non‐B hepatitis in patients from Pakistan. Ann Int Med1987;106:227. CrossRef

48. LudwigJ. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology1993;105:274.

49. KnodellA, IshakKG, BlackWC, et al.Formulation and applications of numerical scoring system for accessing histological activity in asymptomatic chronic active hepatitis. Hepatology1981;1:431. CrossRef

50. IshakKG, BautistaA, BianchiL, et al.Histological grading and staging of chronic hepatitis. J Hepatol1995;22:696. CrossRef

51. BedossaP, Bioulac‐SageT, CallardT, et al.Intra‐observer and inter‐observer variations in liver biopsy interpretations in patients with chronic hepatitis C. Hepatology1994;20:15. CrossRef

52. IshakKG. Pathologic features of chronic hepatitis: a review and update. Am J Clin Pathol2000;113:40. CrossRef

53. GovindarajanS. Use of immunostaining of liver tissue for viral markers. Viral Hepat Rev1998;4:21.

54. GovindarajanS, LimB, PetersRL. Immunohistochemical localization of delta antigen associated with hepatitis B virus in liver biopsy sections embedded in araldite. Histopathology1984;8:63. CrossRef

55. BurgertLJ, BattsKP, LudwigJ, et al.Recent onset autoimmune hepatitis: biopsy findings and clinical correlation. Am J Surg Pathol1995;19:699. CrossRef

56. SnoverDC, HorwitzCA. Liver disease in cytomegalovirus mononucleosis: a light microscopical and immunoperoxidase study of 6 cases. Hepatology1984;4:408. CrossRef

57. Ten NapelCHH, HouthoffHJ, TheTH. Cytomegalovirus hepatitis in normal and immune compromised hosts. Liver1984;4:184.

58. SnoverDC, HuttonS, BalfourHHJr, et al.Cytomegalovirus infection of the liver in transplant patients. J Clin Gastroenterol1987;9:659. CrossRef

59. GoodmanZD, IshakKG, SesterhennIA. Herpes simplex in apparently immuno‐competent adults. Am J Clin Pathol1986;85:694.

60. UchidaT, KaoH, Quispe‐SjogrenM, et al.Alcoholic foamy degeneration: a pattern of acute alcoholic injury of the liver. Gastroenterology1983;84:683.

61. EdmondsonHA, PetersRL, ReynoldsTB, et al.Sclerosing hyaline necrosis of the liver in the chronic alcoholic. Ann Int Med1963;59:646. CrossRef

62. EdmondsonHA. Pathology of alcoholism. Am J Clin Pathol1980;74:725.

63. LeeRG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol1989;20:594. CrossRef

64. BruntEM, JanneyCG, Di BisceglieAM, et al.Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol1999;94:2467. CrossRef

65. LewisJH, MullickF, IshakKG, et al.Histopathologic analysis of suspected amiodarone hepatotoxicity. Hum Pathol1990;21:59. CrossRef

66. RosmanAS, WaraichA, GalvinK, et al.Alcoholism is associated with hepatitis C but not hepatitis B in an urban population. Am J Gastroenterol1996;91:498.

67. SchwimmerJB, BehlingC, NewburyR, et al.Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology2005;42:641. CrossRef

68. KleinerDE, BruntEM, NattaMV, et al.Design and validation of a histological scoring system for non‐alcoholic fatty liver disease. Hepatology2005;41:1313. CrossRef

69. LudwigJ, McDonaldGSA, DicksonER, et al.Copper stains and the syndrome of primary biliary cirrhosis – evaluation of staining methods and their usefulness for diagnosis and trials of pencillamine treatment. Arch Pathol Lab Med1979;103:467.

70. LudwigJ, DicksonER, McDonaldGSA. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch1978;379:103. CrossRef

71. WeisnerRH, LudwigJ, La RussoNF, et al.Diagnosis and the treatment of primary sclerosing cholangitis. Semin Liver Dis1985;5:241. CrossRef

72. IshakKG, ZimmermanHJ. Morphologic spectrum of drug induced hepatic disease. Gastroenterol Clin North Am1995;24:759.

73. KleinerDE, ChalasaniNP, LeeWM, et al.Hepatic histological findings in suspected DILI: systematic evaluation and clinical associations. Hepatology2014;59:661. CrossRef

74. BrugueraM, LamarC, BernetM, et al.Hepatic disease associated with ground‐glass inclusions in hepatocytes after cyanamide therapy. Arch Pathol Lab Med1986;110:906.

75. NakanumaY, LiewCT, PetersRL, et al.Pathologic features of the liver in acquired immune deficiency syndrome (AIDS). Liver1986;6:158. CrossRef

76. CelloJP. Human immunodeficiency virus‐associated biliary tract disease. Semin Liver Dis1992;12:213. CrossRef

77. FriedmanSL. Gastrointestinal and hepatobiliary neoplasms in AIDS. Gastroenterol Clin North Am1988;17:465.

78. DemetrisAJ, BattsKP, DhillonAP, et al.Banff schema for grading liver allograft rejection: An international consensus document. Hepatology1997;25:658. CrossRef

79. DemetrisAJ, AdeyiO, BellamyCO, et al.Banff working group) Liver biopsy interpretation for causes of late liver allograft dysfuction. Hepatology2006;44:489. CrossRef

80. LauJYN, BainBG, DaviesSE, et al.High levels of expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology1992;402:956.

81. DoughtyAL, SpencerJE, CossartYE, et al.Cholestatic hepatitis after liver transplantation associated with persistently high serum hepatitis C virus RNA levels. Liver Transplant Surg1998;4:15. CrossRef

82. FielMI, AgarwalK, StancaC, et al.Post transplant plasma cell hepatitis (De Novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus. Liver Transpl2008;14:861. CrossRef